Labeler · US market

Celgene Corporation

Celgene Corporation is a US drug labeler with US FDA registrations covering 13 drug concepts (13 currently active) across 45 packages. It is currently the only active US supplier of 8 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes59572

Active drugs13

Registrations30 active / 30

Packages45

Sole supplier of8 drugs

Portfolio13 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Lenalidomide capsule	rx	6	12	SUPPLYING
Pomalidomide capsule	rx	4	8	SUPPLYING
Thalidomide capsule	rx	4	5	SUPPLYING
Ozanimod Hydrochloride kit	rx	2	4	SUPPLYING
Idecabtagene Vicleucel suspension	other	1	3	SUPPLYING
Ozanimod Hydrochloride capsule	other	3	3	SUPPLYING
Azacitidine tablet, film coated	rx	2	2	SUPPLYING
Enasidenib Mesylate tablet, film coated	rx	2	2	SUPPLYING
Luspatercept injection, powder, lyophilized, for solution	rx	2	2	SUPPLYING
Azacitidine injection, powder, lyophilized, for solution	rx	1	1	SUPPLYING
Fedratinib Hydrochloride capsule	rx	1	1	SUPPLYING
Romidepsin kit	rx	1	1	SUPPLYING
Ozanimod Hydrochloride capsule	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes59572
Filing names1
Drugs (active)13
Drugs (all time)13
US registrations30
Packages45

Recent events

Shortages, recalls, and registration changes across all filing names.

Dec 18, 2020
SHORTAGEDrug shortage: Azacitidine Injection (Bristol Myers Squibb Co.)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.